Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.


This Document Has Been Replaced By:



This Document Has Been Retired


Up-to-date Information

This is the latest update:

Notes from the Field: Candida auris and Carbapenemase-Producing Organism Prevalence in a Pediatric Hospital Providing Long-Term Transitional Care — Chicago, Illinois, 2019
  • Published Date:

    August 28 2020

  • Source:
    MMWR Morb Mortal Wkly Rep. 69(34):1180-1181
  • Language:
Filetype[PDF-133.51 KB]

  • Alternative Title:
    MMWR Morb Mortal Wkly Rep
  • Description:
    Candida auris is an emerging fungal pathogen that is fre- quently drug-resistant; C. auris can be difficult to identify, and it has been associated with outbreaks in health care settings.* The first case of C. auris in Chicago, Illinois, was identified in May 2016 (1). Additional cases continue to be reported, par- ticularly in high-acuity, postacute–care facilities (1), and spread of C. auris within this type of facility has been documented nationwide (2). To monitor local trends in the prevalence of C. auris, point prevalence surveys (PPSs) have been conducted in Chicago since August 2016 (1). In addition to C. auris, a high prevalence of carbapenemase-producing organisms (CPOs) has also been described in Chicago long-term acute- care hospitals since 2010 (3). C. auris and CPOs can colonize persons over prolonged periods and, because of antimicrobial resistance, cause invasive infections with limited treatment options (2,3). Co-colonization with these organisms has been identified (4). Adults in long-term acute-care hospitals are at increased risk for acquiring C. auris and CPOs because of seri- ous underlying medical conditions, extended lengths of stay, presence of indwelling medical devices, and frequent health care worker contact (3,4). As of June 2019, among residents of Chicago’s four long-term acute-care hospitals, the median prevalences of colonization with C. auris and CPO were 31% and 24%, respectively (Chicago Department of Public Health, personal communication, January 3, 2020). Although preva- lence among adults is well characterized, prevalence of C. auris colonization has not been described among pediatric popula- tions in Chicago, and limited data exist on CPO colonization among children outside of intensive care units (5).
  • Pubmed ID:
  • Pubmed Central ID:
  • Document Type:
  • Place as Subject:
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: